Immunogenicity Evaluating of the Multivalent COVID-19 Inactivated Vaccine against the SARS-CoV-2 Variants

It has been reported that the novel coronavirus (COVID-19) has caused more than 286 million cases and 5.4 million deaths to date. Several strategies have been implemented globally, such as social distancing and the development of the vaccines. Several severe acute respiratory syndrome coronavirus 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuntao, Tan, Wenjie, Lou, Zhiyong, Huang, Baoying, Zhou, Weimin, Zhao, Yuxiu, Zhang, Jin, Liang, Hongyang, Li, Na, Zhu, Xiujuan, Ding, Ling, Guo, Yancen, He, Zhenyu, He, Yao, Wang, Zhanhui, Ma, Bo, Ma, Meng, Zhao, Suhua, Chang, Zhen, Zhao, Xue, Zheng, Xiaotong, Wu, Guizhen, Wang, Hui, Yang, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228943/
https://www.ncbi.nlm.nih.gov/pubmed/35746564
http://dx.doi.org/10.3390/vaccines10060956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228943/
https://www.ncbi.nlm.nih.gov/pubmed/35746564
http://dx.doi.org/10.3390/vaccines10060956

Ejemplares similares